Replies to post #13908 on BioCurex, Inc.(fka BOCX)

[opportunityknocking]

IMO, start saving up now....we are about to have more independent verification. We will make believers out of anyone who wishes to challenge our results. Now that speaks volumes about the truth as to how confident Dr Moro and his team are. He developed so many different ways to detect cancer using Recaf that there won't be one physician, laboratory, hospital, educational, or research institution that wouldn't want to put Recaf to the test. I'm sorry no one else sees the true genious of what is going on at Biocurex, but I completely grasp what they are working towards and I can honestly say that I am impressed with what they have achieved in such a short period of time. They are not working with a light switch they can simply turn off and on. This is some amazing science being done, and it hurts me deeply to feel as though some on this board would love to see this fail. To the bashers, I'm sorry to say that there are individuals within Biocurex that feel compelled to do everything in their power to see this succeed, and IMO, from what I see and hear, it will become a reality.
I hate to put it in these terms, but wouldn't you want to know you have cancer at stage 1 or would you rather go around undetected or have your doctor tell you to close the door and sit down, I'm sorry to tell you this, but you have stage 4 cancer. I am sorry, but you have 2 months to live. This is real. Everyone will benefit. I think a majority of people are predisposed or have someone close to them that has suffered. Unfortunately, it isn't written anywhere how each individual will expire, but you certainly can derail that ill fate if you knew you could be tested. I just don't see too many more obstacles ahead. Dr Moro just has to make believers out of more people, and now he can. That was the importance of his last press release. Dr Moro continues to deliver. I noticed he has stopped wasting our money on the penny news letters. He is on the right track by getting Recaf into the hands of any naysayers or skeptics and is attending another oncology conference. (Also notice he preannounced his invitation to the oncology conference, unlike his last debacle when he did not). It appears as though he is listening to shareholders and has corrected his previous mistakes. If you think that this is one big charade Dr Moro will be presented with an Oscar for his performance. IMO, I strongly feel that he will be accepting another award....the Nobel Prize.

[Gold Seeker]

"after talking with his wife, who is a surgeon, he figures that things with BOCX just don't add up. A cousin of mine, who has her PHD in molecular biology, and who is with a very large pharma, is not convinced either."

Ted, I have gone about as deeply as my ability allows in researching RECAF and Biocurex.

It definitely has some strikes against it.

1. It was founded as a pump and dump.
2. It is esentially a one man operation run out of Vancouver, the home of scams probably second only to Nigeria.
3. The scam founding left the company dead broke with a lot of shares outstanding.
4. Finally, the isolation of a glycoprotein feeding cancer cells is so simple it seems untrue.

The problem is how do you get a cancer test FDA approved as a stand alone test to detect cancer? The answer is, "probably you cannot." Even if it got approved, you can just see insurance carriers falling all over themselves to pay for PET and CAT scans and possibly finding nothing. IMO, RECAF has to be paired with another specific marker to refine its accuracy. Otherwise, you are dealing with a blood chemistry test used off label which is where I see the latest manual test is going. That is easy to validate and probably a 510(k) for FDA approval. Unfortunately, the hard part then commences...getting physicians to use it.

[i_invest_utrade]

I will take the words of a surgical oncologist...

http://findarticles.com/p/articles/mi_m0DHC/is_7_17/ai_n13823920

Things add up. Sometimes people can't see the forest for the trees.

Cash position is still the open question.